CIK 0001287098 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
MAXCYTE, INC.
Sign in to watch- Ticker
- MXCT
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 522210438
- Phone
- 301-517-5556
- Business address
- 9713 KEY WEST AVENUE,, SUITE 400, ROCKVILLE, MD, 20850
- Former names
- MAXCYTE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 42 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-10-02 | Erck Stanley C Director | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −21,607 | 47,689 | ||
| 2024-10-01 | Erck Stanley C Director | Option exercise 10b5-1 | +26,082 | $0.04 | $1K | 295,200 |
| 2024-10-01 | Erck Stanley C Director | Sale 10b5-1 | −26,082 | $3.78 | $99K | 269,118 |
| 2024-10-01 | Erck Stanley C Director | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −26,082 | 69,296 | ||
| 2024-09-26 | Johnston John Joseph Director | Option exercise 10b5-1 | +3,000 | $2.93 | $9K | 144,950 |
| 2024-09-26 | Johnston John Joseph Director | Sale 10b5-1 | −3,000 | $3.82 | $11K | 141,950 |
| 2024-09-26 | Johnston John Joseph Director | Option exercise · Stock Option (right to buy) 10b5-1 | −3,000 | 4,396 | ||
| 2024-09-16 | Soleymannezhad Ali Chief Commercial Officer | Grant or award | +10,400 | 26,025 | ||
| 2024-09-16 | Soleymannezhad Ali Chief Commercial Officer | Grant or award · Employee Stock Option (right to buy) | +20,800 | 20,800 | ||
| 2024-09-04 | Erck Stanley C Director | Option exercise 10b5-1 | +29,767 | $0.04 | $1K | 298,885 |
| 2024-09-04 | Erck Stanley C Director | Sale 10b5-1 | −29,767 | $3.97 | $118K | 269,118 |
| 2024-09-04 | Erck Stanley C Director | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −29,767 | 95,378 | ||
| 2024-09-03 | Erck Stanley C Director | Option exercise 10b5-1 | +17,922 | $0.04 | $717 | 287,040 |
| 2024-09-03 | Erck Stanley C Director | Sale 10b5-1 | −17,922 | $4.10 | $73K | 269,118 |
| 2024-09-03 | Erck Stanley C Director | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −17,922 | 125,145 | ||
| 2024-08-26 | Johnston John Joseph Director | Option exercise 10b5-1 | +3,000 | $2.93 | $9K | 144,950 |
| 2024-08-26 | Johnston John Joseph Director | Sale 10b5-1 | −3,000 | $4.28 | $13K | 141,950 |
| 2024-08-26 | Johnston John Joseph Director | Option exercise · Stock Option (right to buy) 10b5-1 | −3,000 | 7,396 | ||
| 2024-08-02 | Ross Thomas M. EVP, GLOBAL SALES | Option exercise 10b5-1 | +17,857 | $1.64 | $29K | 42,857 |
| 2024-08-02 | Ross Thomas M. EVP, GLOBAL SALES | Sale 10b5-1 | −17,857 | $4.36 | $78K | 25,000 |
Page 5 of 15 · 282 trades